• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVIS & GECK CARIBE LTD UNKNOWN VERSAPORT TROCAR; LAPAROSCOPE, GENERAL & PLASTIC SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVIS & GECK CARIBE LTD UNKNOWN VERSAPORT TROCAR; LAPAROSCOPE, GENERAL & PLASTIC SURGERY Back to Search Results
Model Number UNKNOWN VERSAPORT TROCAR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Blood Loss (2597)
Event Date 10/08/2019
Event Type  Injury  
Manufacturer Narrative
Title: short-term outcomes of single-port versus conventional laparoscopic sleeve gastrectomy: a propensity score matched analysis source: surgical endoscopy (2020) 34:3978¿3985 published online: 8 october 2019.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the literature, (january 2015 to december 2016) this study aimed to assess the outcome of a short-term outcomes of single-port versus conventional laparoscopic sleeve gastrectomy.With regards to morbidity, weight loss, and co-morbidity resolution.From each of these surgical categories, 314 patients were successfully matched which created the ¿matched cohort¿ group.Total matched cohort postoperative outcomes for the spsg category includes: 90 day postoperative complications (27) ; bleeding intra-abdominal or intraluminal 8); dindo-clavien grade > iiia (14) incisional hernia (5).The ¿dindo-clavien > iiia complications¿ included 13 patients; one patient that presented a post-operative hematoma treated by percutaneous drainage under local anesthesia (iiia).Total matched cohort postoperative outcomes for the clsg category includes: 90 day postoperative complications (21) ; bleeding intra-abdominal or intraluminal (8); dindo-clavien grade > iiia (7); incisional hernia (1).The ¿dindo-clavien > iiia complications¿ included 7 patients: two patients that presented a postoperative hematoma treated by percutaneous drainage under local anesthesia (iiia).Short-term outcomes of single-port versus conventional laparoscopic sleeve gastrectomy: a propensity score matched analysis | hadrien tranchart1,2 · lionel rebibo3,4 · martin gaillard1,2 · abdennaceur dhahri3,4 · panagiotis lainas1,2 ·jean-marc regimbeau3,4 · ibrahim dagher1,2 | department of minimally invasive digestive surgery, antoine béclère hospital, ap-hp, 157 rue de la porte de trivaux, 92140 clamart, france | received: 1 march 2019 / accepted: 26 september 2019 / published online: 8 october 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN VERSAPORT TROCAR
Type of Device
LAPAROSCOPE, GENERAL & PLASTIC SURGERY
Manufacturer (Section D)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DO  0101
Manufacturer (Section G)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DO   0101
Manufacturer Contact
lisa hernandez
60 middletown ave
north haven, CT 06473
2034925563
MDR Report Key10676581
MDR Text Key211292566
Report Number9612501-2020-01462
Device Sequence Number1
Product Code GCJ
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 10/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN VERSAPORT TROCAR
Device Catalogue NumberUNKNOWN VERSAPORT TROCAR
Was Device Available for Evaluation? No
Date Manufacturer Received09/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
-
-